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macrophage infiltration (P < 0.01 vs vehicle) and -smooth muscle actin expres-
sion (P < 0.01 vs vehicle). Gelatin zymography revealed that MMP-2 levels were
significantly increased with combination therapy (P < 0.01 vs. vehicle, P < 0.05
vs. MSC or serelaxin alone). In vivo tracing studies showed MSCs homed to the
UUO-injured kidney within 1 hour post transplantation where they remained for
36 h. Serelaxin also significantly increased MSC proliferation in vitro (14%;
P < 0.05).
Conclusions: This study is the first demonstrate that when used in combination,
MSCs and the antifibrotic serelaxin, ameliorate pathological fibrosis and improve
MSC-mediated repair, in part, via through the up-regulation of MMP-2.
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LEAD TIME BIAS IN PRE-EMPTIVE LIVING
KIDNEY DONOR TRANSPLANTATION
P CLAYTON1,2,3, S MCDONALD1,4, S CHADBAN1,2,3
1Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry,
Adelaide, SA; 2Sydney Medical School, University of Sydney, Sydney, NSW;
3Department of Transplantation, Royal Prince Alfred Hospital, Sydney, NSW;
4Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia
Aim: To explore the impact of lead time bias in survival comparisons of pre-
emptive vs non pre-emptive living donor kidney transplants.
Background: Pre-emptive and non pre-emptive living kidney donor transplants
have similar post-transplant patient survival. However, pre-emptive transplants
occur earlier in a patient’s disease course and this “lead time” may bias survival
comparisons.
Methods: Using the Australia and New Zealand Dialysis and Transplant
(ANZDATA) Registry, we included adult living donor kidney recipients over
1993–2012 who were transplanted pre-emptively (n = 1237) or after up to 6
months of dialysis (controls, n = 3375). Patients were matched 1:1 by propensity
score. Two sources of lead time were added to post-transplant survival times: (1)
Dialysis lead time (pre-transplant dialysis duration) and (2) CKD lead time
(estimated as the difference in eGFR at commencement of renal replacement
therapy (RRT) divided by the assumed rate of CKD progression, with different
assumed rates modelled). Survival of pre-emptive and control patients was com-
pared using Cox models.
Results: Pre-emptive recipients were more commonly Caucasian, commenced
RRT with higher eGFR (median 9.2 vs 6.3 mL/min/1.73 m2) and had fewer
co-morbidities. Before matching, pre-emptive transplantation was strongly pro-
tective (HR 0.50, 95%CI: 0.39–0.65). After matching there were 539 patients
included in each group, and the protective effect was no longer evident (HR 1.17,
95%CI: 0.73–1.87). Adjusting for lead time bias enhanced survival of controls
over pre-emptives, although survival was not statistically different across a clini-
cally relevant range of eGFR decline rates.
Conclusions: Adjustment for lead time bias neutralises the apparent survival
advantage of pre-emptive living donor transplantation. Further studies with
larger numbers are needed to confirm this observation.
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BASELINE CHARACTERISTICS OF THE PATIENTS
PARTICIPATING IN THE FAVOURED TRIAL
A IRISH On Behalf of The Favoured Steering Committee and Australasian
Kidney Trials Network
Royal Perth Hospital, Perth, WA, Australia
Aim: To present the baseline characteristics of the FAVOURED Trial
participants.
Background: The FAVOURED Study is an international randomised, double-
blind placebo controlled factorial trial examining whether the use of aspirin and
omega-3 fatty acids (fish oil), either alone or in combination, reduces the risk of
early failure of de novo arteriovenous (AV) fistula.
Methods: Demographic and clinical features of 568 participants enrolled at 35
sites in Australia, New Zealand, Malaysia and United Kingdom are presented.
Results: 403 participants from Australia and New Zealand (ANZ), 156 from
Malaysia and 9 from United Kingdom. Mean age was 54.8 ± 14.3, 63.5% were
males, 52.8% Caucasian and 32.1% Asian. Diabetes was the commonest cause
(62.1% in Malaysia and 29.9% in ANZ) although both regions had low preva-
lence of ischaemic heart disease (4.5% Malaysia vs 8.2% ANZ). Site of the
planned fistula differed with 51.9% Malaysian patients having upper-arm AVF
compared with 34% in ANZ (P < 0.0001). 60.8% of Malaysians were receiving
dialysis (all haemodialysis) compared with 47.4% in ANZ (35.7% utilising HD
and the remaining 11.7% with functioning transplant or on PD); P = 0.005. Type
of access also differed between regions with 89.2% in Malaysia using non-cuffed
catheters and 88.6% of ANZ patients using cuffed catheters. Malaysian patients
were relatively more anaemic (Hb 92 vs 112 gm/L; P < 0.0001).
Conclusions: A number of regional differences in demographic and clinical
characteristics were identified. The FAVOURED trial demonstrates the benefits
of multinational collaboration: enabling more effective recruitment and ensuring
inclusiveness and diversity of the study subjects resulting in better generalisability
of the trial results.
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ANYTHING BUT A SIMPLE SURGICAL
PROCEDURE: PATIENTS’ PERSPECTIVES OF
VASCULAR ACCESS FOR HAEMODIALYSIS
JR CASEY1,2, CS HANSON1,2, WC WINKELMAYER3, JC CRAIG1,2,
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Westmead, New South Wales, Australia; 3Stanford University, Palo Alto, United
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Aim: To describe patients’ perspectives on vascular access initiation and main-
tenance in haemodialysis.
Background: Delayed creation of vascular access is associated with adverse out-
comes and may be partly due to patient refusal. Concerns about vascular access
are prevailing treatment-related stressors for patients on haemodialysis.
Methods: MEDLINE, Embase, PsycINFO, CINAHL, reference lists, PhD disser-
tations were searched to December 2013. Qualitative studies that assessed the
attitudes and experiences of patients with chronic kidney disease (CKD) on
vascular access were synthesized thematically.
Results: Forty-six studies involving1034 patients (haemodialysis [n  761]; peri-
toneal dialysis [n  67]; non-dialysis dependent [n  42]; unspecified modality
[n  164]) were included. Six themes were identified: heightened vulnerability
(bodily intrusion, cannulation fears, threat of complications, unpreparedness,
dependence on a lifeline, wary of unfamiliar providers); disfigurement (preserving
appearance, visual reminder of disease, avoiding stigma); bodily mechanisation
(bonded to a machine, internal abnormality, constant maintenance); impinging
on way of life (physical incapacitation, instigating family tension, wasting time,
added expense); self-preservation and ownership (task-focussed control, advocat-
ing for protection, acceptance) and confronting decisions and consequences
(imminent dialysis, existential thoughts). Apparent differences across access
types were primarily related to complications; clotting, infiltration and stenosis
were emphasized with fistula and graft use, whereas infections were a predominant
concern in catheter use.
Conclusions: Vascular access is more than a surgical intervention; it signifies
imminent dialysis, which is emotionally confronting. Patients strive to preserve
their access for survival; but simultaneously describe it as an agonizing reminder
of their body’s failings and “abnormality” of being amalgamated with a machine,
disrupting their identity and lifestyle. Timely education and counselling and
building patients’ trust in providers may improve the quality of dialysis and lead
to better outcomes for patients on haemodialysis.
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INDICATIONS FOR FISTULOGRAPHY AND
CORRELATION WITH DETECTION OF
ARTERIOVENOUS FISTULA STENOSIS
I ISMAIL1, RA BAER 1, M MANTHA1, BL NEUEN1, F GRAINER1,
R GUNNARSSON2
1Division of renal medicine, Cairns Base Hospital, Cairns, Queensland; 2School of
Medicine and Dentistry, James Cook University, Cairns, Queensland, Australia
Aims: To identify the indications for fistulograms and determine correlation
between indication and radiological findings.
Background: Dialysis access stenosis is the most common cause of access dys-
function. Clinical monitoring or vascular access surveillance abnormalities
prompt a fistulogram. At our institution, fistulogram is primarily used to confirm
stenosis.
Methods: A retrospective observational study was conducted on 245
fistulograms performed at our institution over a two year period from January 2012
to December 2013. The indication for referral, fistulogram findings, type of fistula
and demographic data were obtained.
Results: Total of 75.5% (185 of 245) fistulograms performed confirmed stenosis.
The most frequent clinical indication was high venous pressures – 18.4% (45 of
245) and the most common surveillance indication was abnormal access flow
(Transonic®) – 17.1% (42 of 245).
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The average age was 57 years, with 35.9% Aboriginal and 28.2% Torres Straight
Islander ethnicity. The most common type of vascular access was radiocephalic
fistula (49.8%) followed by brachiocephalic fistula (43.3%).
Further analysis of variables, using bivariate logistic regression analysis, failed
to reveal any significant correlation between indications for referral and finding of
stenosis. However, increased venous pressure tends to be associated with stenosis
(Odds ratio 2.0, 95% CI = 0.84–4.7, P = 0.12).
Both venous hypertension (Odds ratio 0.10, 95% CI = 0.011–1.0, P = 0.052)
and development of collaterals (Odds ratio 0.077, 95% CI = 0.0084–0.70,
P = 0.023) were associated with negative fistulograms.
Conclusions: At our institution, the majority of fistulograms demonstrated
access stenosis, based on established referral indications. Both venous hyperten-
sion and development of collaterals as referral indications were associated with
less likelihood of finding vascular access stenosis in this cohort.
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INITIAL EVALUATION OF PLASTIC
HAEMODIALYSIS CANNULAE IN AN
AUSTRALIAN CENTRE
R BAER, M MANTHA, F GRAINER
Renal Department, Cairns and Hinterland Hospital and Health Service, Cairns,
Queensland, Australia
Aim: To describe an initial experience using plastic haemodialysis cannulae
(PHC) in difficult access situations.
Background: PHC have been used internationally for haemodialysis access and
may offer the advantage of lower profile for gauge, length for deeper fistulae, and
less chance of trauma/migration with arm movement. Our unit has used PHC
particularly in difficult cannulation situations.
Methods: Standard dialysis practice data about PHC (Argyle®, Covidien) were
gained prospectively during a single centre evaluation period between first use in
October 2013 and March 2014. Complications, effective blood flow rates,
maximum arterial and venous pressures, cannula gauge, use of ultrasound, and
comments by the inserting nurses were described.
Results: 226 plastic cannulae were inserted into 23 patients over 107 dialysis
sessions by 7 dialysis nurses. Indication for the majority was deep fistula, known
difficult cannulation, or preceding haematoma formation limiting accessible sites.
Difficulty related to patient issues was reflected in ultrasound use in 83% (187/
226). Effective blood flows 300 mL/min were achieved in 87% (72 of 83 ses-
sions). The remainder achieved between 230 and 280 mL/min. Median (and
range) of arterial and venous pressures were 140 (40–200) and 130 (100–200)
mmHg respectively. In the majority of instances 15G cannulae were used (218/
226). 24 attempts failed due to PHC technique failure, of which two resulted in
infiltration.
Conclusion: Plastic haemodialysis cannulae can facilitate satisfactory perfor-
mance of dialysis achieving desirable flow parameters especially in those patients
with difficult access. Comparative, prospective studies are required to determine
equivalence/superiority and address longer term access patency.
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PRACTICE CHANGES DECREASE BUTTONHOLE
INFECTION RATES IN HOME HAEMODIALYSIS
PATIENTS
Y PARK, P TSANG, F SIU, E MISSION, L HABERECHT, R
SACREMENTO, K GRIMELY, J SAUNDERS, P CLAYTON, P SNELLING
State-Wide Renal Service, Royal Prince Alfred Hospital, Camperdown, Sydney,
NSW 2050, Australia
Aim: To describe infection rates of buttonhole cannulation (BHC) related to
changes in hygiene practices in home haemodialysis patients (HHD).
Background: Buttonhole cannulation has been associated with greater rates of
infection compared to standard cannulation of arteriovenous fistulae (AVF),
although not all studies confirm this finding. We report infection rates of button-
hole cannulation of AVF in HHD over 10 years, before and after changes in
practice of skin preparation procedure and the use of topical mupirocin prophy-
laxis (TMP).
Methods: We observed 169 patients (pts) using native AVF with BHC and
compared the infection events rates, with a cumulative treatment duration of
189,720 AVF-days, between 2004 and 2013 in three different stages; 1) 108 pts
with pre-new BHC technique procedures (BHCTP) for 100,530 AVF-days –
Stage 1, and 2) 66 pts with new BHCTP for 25,050 AVF-days – Stage 2, and 3)
99 pts with post-new BHCTP with TMP for 64,140 AVF-days – Stage 3.
Results: A total of 45 BH infection episodes (systemic – 23episodes, local –
22episodes) were identified, giving a cumulative infection rate of 0.236/1000
AVF-days. The comparison of infection rates in the three different stages was:
Stage 1 – 0.358 events/1000 AVF-days (0.25–0.50) with 36 infection episodes
(systemic 19, local 17), Stage 2 – 0.319 events/1000 AVF-days (0.14–0.63) with
8 infection episodes (systemic 4, local 4), Stage 3 – 0.016 events/1000 AVF-days1
(0.00–0.09) infection episode (1 local). There was a significant difference
between Stage 3 and Stage 1 and 2 (P < 0.0001).
Conclusion: Infection rates in buttonhole cannulation can be decreased with
strict hygiene procedures and TMP. TMP use was associated with significantly
lower risk of infection and should be considered in any patient using BHC.
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DEATH DUE TO HAEMODIALYSIS VASCULAR
ACCESS HAEMORRHAGE
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Aim: To identify, quantify and collate deaths due to bleeding from haemodialysis
vascular access.
Background: Haemodialysis requires access to the circulation via either a syn-
thetic vascular catheter or an arteriovenous fistula or graft. To prevent clotting,
regular anticoagulation (most commonly heparins) is given. Whilst not common,
anecdotally there have been a number of dialysis patients dying due to a signifi-
cant bleed from their dialysis access.
Methods: A retrospective review of ANZDATA from 1964 to 31/12/2012, for all
persons dying where cause of death was recorded as death due to dialysis access
haemorrhage. Further information was requested from the treating units about
these specific deaths.
Results: Recorded on ANZDATA, 90 people (57 female) receiving renal
replacement therapy died due to dialysis access haemorrhage, including 55 since
1/1/2000. Mean age was 63.7 years (range 17–87 years). Modality at the time of
death included 42 (47%) on Hospital HD, 27 (30%) on Satellite HD, 19 (21%)
on Home HD, 2 (2.2%) on Peritoneal dialysis, but none with a functioning
transplant. Comorbidities included diabetes in 37%, coronary disease in 56% and
13% were current smokers. Prior to death recorded pathology included mean Hb
110 ± 19 g/dL (range 70–169 g/L) and 88.7% were on an ESA. Access in use at
the time of death included native fistula 53%, synthetic graft 30%, tunnelled
catheter 11%, and temporary catheter 6%.
Conclusions: Death due to dialysis access haemorrhage is a rare but potentially
preventable adverse event.
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CHANGES IN CARDIAC INDICES AFTER A-V
FISTULA LIGATION OR THROMBOSIS IN STABLE
RENAL TRANSPLANT PATIENTS
A GUJADHUR1, J MARTIN2, P BERGIN2, S MENAHEM1
1Department of Renal Medicine, Alfred Hospital, Melbourne, Victoria; 2Department
of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia
Background: An arterio-venous fistula (AVF) increases stroke volume and
cardiac output and can lead to high output cardiac failure. It may also contribute
to left ventricular hypertrophy (LVH) in renal failure patients. Following renal
transplant, cardiac parameters often improve in dialysis patients, but the presence
of a functioning, high-flowAVFmay impair full recovery of cardiac abnormalities.
Aim: To measure the changes in cardiac parameters and function induced by
elective AVF ligation or spontaneous thrombosis in stable renal transplant
patients. AVF were ligated for cosmetic reasons or due to chronic pain.
Methods: Nine patients were eligible for inclusion during the study period. A
transthoracic echocardiogram was performed on all patients prior to ligation or
thrombosis of their AVF and 3 months following occlusion. Parameters measured
included stroke volume, heart rate, cardiac output, left ventricular (LV) ejection
fraction, LV mass index and wall thickness.
Results: There was a significant fall in mean heart rate (78 vs. 66 bpm,
P = 0.04), stroke volume (91 vs. 76 mL, P = 0.039), cardiac output (7.1 vs.
4.7 L/min, P = 0.002) and cardiac index (3.9 vs. 2.5 L/min/m2 BSA, P = 0.002)
post AVF ligation. Mean LV ejection fraction increased and LV mass index was
lower post fistula ligation although the results did not reach statistical signifi-
cance. There was no significant change in LVH.
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